Explore

Trendline Trendline
Adagio Medical Reports Q1 2026 Financial Results and Advances in Cardiac Arrhythmia Treatment

Adagio Medical Reports Q1 2026 Financial Results and Advances in Cardiac Arrhythmia Treatment

Adagio Medical Reports Q1 2026 Financial Results and Advances in Cardiac Arrhythmia Treatment
Trendline Trendline
Adagio Medical Reports Q1 2026 Financial Results and Clinical Progress

Adagio Medical Reports Q1 2026 Financial Results and Clinical Progress

Adagio Medical Reports Q1 2026 Financial Results and Clinical Progress
Trendline Trendline
Atara Biotherapeutics Reports Significant Revenue Decline and Operational Updates for Q1 2026

Atara Biotherapeutics Reports Significant Revenue Decline and Operational Updates for Q1 2026

Atara Biotherapeutics Reports Significant Revenue Decline and Operational Updates for Q1 2026
Trendline Trendline
Anteris Technologies Reports Q1 2026 Financial Results with Increased Net Loss

Anteris Technologies Reports Q1 2026 Financial Results with Increased Net Loss

Anteris Technologies Reports Q1 2026 Financial Results with Increased Net Loss
Trendline Trendline
Anteris Technologies Reports Q1 2026 Financial Results with Revenue Decline

Anteris Technologies Reports Q1 2026 Financial Results with Revenue Decline

Anteris Technologies Reports Q1 2026 Financial Results with Revenue Decline
Trendline Trendline
Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call

Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call

Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call
Trendline Trendline
Veracyte Reports Strong Q1 Earnings, Boosting Stock by 23%

Veracyte Reports Strong Q1 Earnings, Boosting Stock by 23%

Veracyte Reports Strong Q1 Earnings, Boosting Stock by 23%
Trendline Trendline
Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Advances

Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Advances

Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Advances
Trendline Trendline
Immunome Advances Oncology Pipeline with New Drug Application and Clinical Trials

Immunome Advances Oncology Pipeline with New Drug Application and Clinical Trials

Immunome Advances Oncology Pipeline with New Drug Application and Clinical Trials
Trendline Trendline
AN2 Therapeutics Reports Q1 2026 Financial Results and Pipeline Updates

AN2 Therapeutics Reports Q1 2026 Financial Results and Pipeline Updates

AN2 Therapeutics Reports Q1 2026 Financial Results and Pipeline Updates
Trendline Trendline
Veradermics Reports Q1 2026 Financial Results and Clinical Progress in Hair Loss Treatment

Veradermics Reports Q1 2026 Financial Results and Clinical Progress in Hair Loss Treatment

Veradermics Reports Q1 2026 Financial Results and Clinical Progress in Hair Loss Treatment
Trendline Trendline
Anteris Technologies Initiates US PARADIGM Trial Enrolment with Significant Funding Boost

Anteris Technologies Initiates US PARADIGM Trial Enrolment with Significant Funding Boost

Anteris Technologies Initiates US PARADIGM Trial Enrolment with Significant Funding Boost